Click here for an accessible version of this site

References

  1. MENACTRA vaccine [Prescribing Information]. Swiftwater, PA: Sanofi Pasteur Inc; 2007.
  2. Centers for Disease Control and Prevention (CDC). Vaccine information statement. Meningococcal vaccines: what you need to know. http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-mening.pdf. Accessed February 25, 2008.
  3. National Meningitis Association. About meningitis. http://www.nmaus.org/about_meningitis/index.htm. Accessed February 25, 2008.
  4. Keyserling H, Papa T, Koranyi K, et al. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents. Arch Pediatr Adolesc Med. 2005;159(10):907-913.
  5. Granoff DM, Harrison LH, Borrow R. Meningococcal vaccines. In: Plotkin SA, Orenstein WA, eds.Vaccines. 5th ed. Philadelphia, PA: WB Saunders Co.; 2008.
  6. World Health Organization. Fact sheet No. 141: meningococcal meningitis. http://www.who.int/mediacentre/factsheets/fs141/en/. Accessed February 25, 2008.
  7. CDC. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2007;54(RR-7):1-21.
  8. Erickson LJ, De Wals P, McMahon J, Heim S. Complications of meningococcal disease in college students. Clin Infect Dis. 2001;33(5):737-739.
  9. Warren HS Jr, Gonazalez RG, Tian Di. Case records of the Massachusetts General Hospital. Case 38-2003: A 12-year-old girl with fever and coma. N Engl J Med. 2003;349(24):2341-2349.
  10. CDC. Recommended immunization schedules for persons aged 0-18 years — United State, 2008. MMWR. 2008;57(1):Q1-Q4.
  11. CDC. Update: Guillain-Barré syndrome among recipients of Menactra® meningococcal conjugate vaccine — United States, June 2005-September 2006. MMWR. 2006;55(41):1120-1124.
  12. Harrison LH, Pass MA, Mendelsohn AB, et al. Invasive meningococcal disease in adolescents and young adults. JAMA. 2001;286(6):694-699.
  13. CDC. VFC operations guide: module 1 - overview. http://www.cdc.gov/vaccines/programs/vfc/operations-guide.htm. Accessed February 25, 2008.
  14. CDC. Summary of notifiable diseases — United States, 2004. MMWR. 2004;53(53):1-81.
  15. CDC. Summary of notifiable diseases — United States, 2005. MMWR. 2005;54(53):1-92.
  16. CDC. Summary of notifiable diseases — United States, 2006. MMWR. 2006;55(53):1-94.
  17. CDC. Revised recommendations of the Advisory Committee on Immunization Practices to vaccinate all persons aged 11-18 years with meningococcal conjucate vaccine. MMWR. 2007;56(31):794-795.
  18. Shoham S, Cover C, Donegan N, Fulnecky E, Kumar P. Cyrptococcus neoformans meningitis at 2 hospitals in Washington, D.C.: adherence of health care providers to published practice guidelines for the management of cryptococcal disease. Clin Infect Dis. 2005;40(3):477-479.
  19. Infectious: viral meningitis. Meningitis Foundation of America Web site. http://www.meningitisfoundationofamerica.org/templates/content-view/85/index.html. Accessed March 23, 2008.
  20. National Conference of State Legislatures. Meningitis laws by state. http://www.ncsl.org/programs/health/meningitisleg.htm. Accessed March 7, 2008.
  21. Alaska State Legislature. HR 185, 24th Leg. http://www.legis.state.ak.us/basis/get_bill_text.asp?hsid=HB0185Z&session=24. Accessed March 7, 2008.
  22. State of Arkansas. HR 2136, 82nd General Assembly. http://www.arkleg.state.ar.us/assembly/1999/R/Bills/HB2136.pdf. Accessed March 7, 2008.
  23. California State Legislature. AB 1452. http://www.leginfo.ca.gov/pub/01-02/bill/asm/ab_1451-1500/ab_1452_bill_20011001_chaptered.html. Accessed March 7, 2008.
  24. Colorado General Assembly. http://www.leg.state.co.us/clics2004a/csl.nsf/fsbillcont/B4B3641B6712E14987256DE1006A0DFC?Open&file=057_01.pdf. Accessed March 7, 2008.
  25. Connecticut General Assembly. http://www.cga.ct.gov/2001/FC/pdf/2001HB-05675-R000721-FC.pdf. Accessed March 7, 2008.
  26. Delaware General Assembly. http://www.nmaus.org/pdf/DE_law.pdf. Accessed March 7, 2008.
  27. Florida State Legislature. HR 871. http://www.leg.state.fl.us/data/session/2002/House/bills/billtext/pdf/h0871c1.pdf. Accessed March 7, 2008.
  28. Georgia State Assembly. HR 521. http://www.legis.state.ga.us/legis/2003_04/fulltext/hb521.htm. Accessed March 7, 2008.
  29. Illinois General Assembly. http://www.ilga.gov/legislation/publicacts/pubact92/acts/92-0089.html. Accessed March 7, 2008.
  30. Indiana State Department of Health. Digest of SB326. http://www.in.gov/legislative/bills/2005/ES/ES0326.1.html. Accessed June 24, 2008.
  31. Iowa General Assembly. S 2202, 80th General Assembly. http://www.legis.state.ia.us/GA/80GA/Legislation/SF/02200/SF02202/Current.html. Accessed March 7, 2008.
  32. Kansas State Legislature. HR 2752. http://www.kslegislature.org/bills/2006/2752.pdf. Accessed March 7, 2008.
  33. Kentucky General Assembly. HR 342. http://www.lrc.state.ky.us/RECORD/04RS/HB342/bill.doc. Accessed March 7, 2008.
  34. Louisiana State Legislature. HR 154. http://www.legis.state.la.us/billdata/streamdocument.asp?did=477512. Accessed March 7, 2008.
  35. Maine State Legislature. Maine revised statutes. Title 20-A: education. http://janus.state.me.us/legis/statutes/20-a/title20-asec10008.html. Accessed March 7, 2008.
  36. Office of Epidemiology & Disease Control Programs. Maryland Department of Health & Mental Hygiene; Meningococcal disease update. http://edcp.org/html/meningupdate.html. Accessed March 7, 2008.
  37. Commonwealth of Massachusetts. Chapter 228 of the acts of 2004. An act relative to meningitis immunization awareness. http://www.mass.gov/legis/laws/seslaw04/sl040228.htm. Accessed March 7, 2008.
  38. Commonwealth of Massachusetts. Chapter 229 of the acts of 2004. An act requiring college students immunization against meningococcal disease. http://www.mass.gov/legis/laws/seslaw04/sl040229.htm. Accessed March 7, 2008.
  39. Michigan State Legislature. HR 4562, 91st Leg. http://www.legislature.mi.gov/documents/2001-2002/publicact/htm/2001-PA-0163.htm. Accessed March 7, 2008.
  40. Minnesota Senate Legislature. S 2189, 85th Leg. https://www.revisor.leg.state.mn.us/bin/bldbill.php?bill=S2189.0.html&session=ls85. Accesed March 7, 2008.
  41. Mississippi State Legislature. S 2700. http://billstatus.ls.state.ms.us/documents/2006/pdf/SB/2700-2799/SB2700SG.pdf. Accessed March 7, 2008.
  42. Missouri General Assembly. S 686, 92nd General Assembly. http://www.senate.mo.gov/03info/billtext/tat/sb686.htm. Accessed March 7, 2008.
  43. Nebraska State Legislature. LB 513. http://uniweb.legislature.ne.gov/FloorDocs/98/PDF/Slip/LB513.pdf. Accessed March 7, 2008.
  44. State of New Jersey. S 1546, 210th Leg. http://www.njleg.state.nj.us/2002/Bills/A2000/1546_R3.PDF. Accessed March 7, 2008.
  45. National Meningitis Association (NMA). New York Legislation. http://www.nmaus.org/awareness/new-york.htm. Accessed March 7, 2008.
  46. North Carolina General Assembly. S 444. http://www.ncga.state.nc.us/Sessions/2003/Bills/Senate/HTML/S444v5.html. Accessed March 7, 2008.
  47. Ohio General Assembly. HR 142, 125th General Assembly. http://www.legislature.state.oh.us/bills.cfm?ID=125_HB_142. Accessed March 7, 2008.
  48. State of Oklahoma. HR 2942, 50th Leg, 2nd Sess. http://www.oksenate.gov/publications/senate_journals/sj2006/sj20060206.pdf. Accessed March 7, 2008.
  49. Pennsylvania General Assembly. S 955. http://www.legis.state.pa.us/CFDOCS/Legis/PN/Public/btCheck.cfm?txtType=PDF&sessYr=2001&sessInd=0&billBody=S&billTyp=B&billNbr=0955&pn=2102. Accessed March 7, 2008.
  50. State of Rhode Island General Assembly. 98-H 7199B. http://www.rilin.state.ri.us/PublicLaws/Law98/Law98034.htm. Accessed March 7, 2008.
  51. South Carolina Legislature. HR 5133, General Assembly, 114th Sess. http://www.scstatehouse.net/sess114_2001-2002/bills/5133.htm. Accessed March 7, 2008.
  52. State of Tennessee. S 185. http://www.state.tn.us/sos/acts/103/pub/pc0104.pdf. Accessed March 7, 2008.
  53. Texas Legislature Online. S 31. http://www.capitol.state.tx.us/tlodocs/77R/billtext/html/SB00031F.HTM. Accessed March 7, 2008.
  54. Virginia General Assembly. HR 2762. http://leg1.state.va.us/cgi-bin/legp504.exe?011+ful+CHAP0340. Accessed March 7, 2008.
  55. Washington State Legislature. HR 1463, 59th Leg. http://www.leg.wa.gov/pub/billinfo/2005-06/Htm/Bills/Session%20Law%202005/1463-S.SL.htm. Accessed March 7, 2008.
  56. West Virginia Code. S 18B, 78th Leg, 2nd Sess. http://www.legis.state.wv.us/WVCODE/code.cfm?chap=18B&art=1%20B#1%20B. Accessed March 7, 2008.
  57. NMA. Wisconsin Legislation. AB 344. http://www.nmaus.org/awareness/pdf/03Act61.pdf. Accessed March 7, 2008.

Indication
Menactra vaccine is given to persons 2 through 55 years of age for active immunization against invasive meningococcal disease caused by N meningitidis serogroups A, C, Y, and W-135. Menactra vaccine will not stimulate protection against infection caused by N meningitidis other than serogroups A, C, Y, and W-135.

Safety Information
Side effects to Menactra vaccine include injection site pain, redness, and swelling; headache or fatigue. Other side effects may occur. Vaccination should be avoided by persons with known hypersensitivity (severe allergic reaction) to any ingredient of the vaccine, including latex (which is used in the vial stopper), or by any persons previously diagnosed with Guillain-Barré syndrome. There is a potential for an increased chance of getting Guillain-Barré syndrome following vaccination. Vaccination with Menactra vaccine may not protect all individuals.

For more information about Menactra vaccine, talk to your health-care professional.